A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer-Reference-Cited by-同舟云学术

A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer

Published:2014-08-12 Issue:10 Volume:2 Page:949-961
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Chen Gang,Gupta Richa,Petrik Silvia,Laiko Marina,Leatherman James M.,Asquith Justin M.,Daphtary Maithili M.,Garrett-Mayer Elizabeth,Davidson Nancy E.,Hirt Kellie,Berg Maureen,Uram Jennifer N.,Dauses Tianna,Fetting John,Duus Elizabeth M.,Atay-Rosenthal Saadet,Ye Xiaobu,Wolff Antonio C.,Stearns Vered,Jaffee Elizabeth M.,Emens Leisha A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boron Neutron Capture Therapy‐Derived Extracellular Vesicles via DNA Accumulation Boost Antitumor Dendritic Cell Vaccine Efficacy;Advanced Science;2024-07-17

2. Update on current and new potential immunotherapies in breast cancer, from bench to bedside;Frontiers in Immunology;2024-02-15

3. Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options;Breast Cancer: Basic and Clinical Research;2024-01

4. Highlights of current and future for the treatment of resistant HER2+ breast cancer to HER2-targeted therapies;Overcoming Cancers Resistant to HER-2 Antibodies;2024

5. The Promise of Immunotherapeutics and Vaccines in the Treatment of Cancer;Handbook of Oncobiology: From Basic to Clinical Sciences;2024